Silicon Labs reported stronger-than-expected third-quarter results on Tuesday, with revenue of $251 million, up 22% on a year earlier and 10% on the previous quarter. Non-GAAP earnings of $1.05 a share beat the $0.82 consensus by 28%, and were up 228% on the same period last year.

The wireless chip maker said growth was broad-based across its end markets. Industrial and commercial revenue reached $141 million, up 20% year on year, while home and life revenue was $110 million, up 24%. Medical revenue hit a new quarterly record, rising 48% on the previous quarter and more than 300% on a year earlier as known customer programmes continued to ramp up.

Profit recovers from last year's loss

On a GAAP basis, Silicon Labs earned $0.26 a share, compared with a loss of $0.30 a share in the third quarter of 2025. Gross margin was 60.8% on a GAAP basis and 61.0% on a non-GAAP basis. Chief executive Matt Johnson said earnings had significantly outpaced revenue growth as a result of strong operational execution, and that the order backlog and design-win ramps positioned the company for continued revenue growth.

The shares were little changed on the day, closing at $221.61, down 0.1%, after a strong run this year. The stock has added about 69.7% since the start of the year, against a 10.3% gain for the S&P 500, according to Zacks.

No guidance while TI deal pending

Silicon Labs has suspended forward guidance because of its pending acquisition by Texas Instruments. Analysts currently expect fourth-quarter earnings of $0.76 a share on revenue of $243.36 million, according to Zacks consensus estimates. The company has now beaten consensus earnings estimates in each of the past four quarters.

The result underlines demand for low-power wireless chips across industrial, medical and smart-home products, even as the wider chip sector faces volatile trading. Read the full reports at PR Newswire and Zacks.

Frequently asked questions

How much did Silicon Labs earn in Q3? Non-GAAP earnings were $1.05 a share, beating the $0.82 consensus, while GAAP earnings were $0.26 a share against a $0.30 loss a year earlier.

What drove the revenue growth? Industrial and commercial revenue rose 20% to $141 million, home and life rose 24% to $110 million, and medical revenue hit a record, up 48% on the previous quarter.

Why is there no forward guidance? Silicon Labs has suspended guidance because of its pending acquisition by Texas Instruments.